Member Info for Hantsome

Is Harry ok? From most vocal critic of BPC to 5p soon?

There’s more flip-flops on this board than Blackpool pleasure beach.

You know when something feels like it’s being artificially suppressed. To me the lack of any direction at present is very telling, as when the move comes it will be big and sudden.

Have a good weekend folks. Another (very slow) day closer to the prize.

Not that mine is sizeable but I got in today. I suspect I’ll be selling them for more than £500.

11-Mar-21 16:00:56 2.2939 22,222 Buy* 509.75

For a start, I doubt this feeble volume will continue for much longer. Anticipation building into Nasdaq listing. Further clinical data coming and so far it’s been massively encouraging. Potential new financing from industry sector specialists to accelerate our growth.

Apart from that, no real reason.

https://www.lse.co.uk/news/DDDD/uk-shareholder-meetings-calendar-next-7-days-4xfcfi7bqjy228a.html

Things could look a little different.

I like big buts and I cannot lie.

@HeresHopin

Embarrassing that you can’t communicate without resorting to personal insults. Given that you post on average 5.5 times a day and clearly live on an Internet forum, I’d expect better really.

@HeresHopin so you think it’s a good name then?

Pro-Larva is such a woeful name to have chosen.

Pal-larva in the marketing department when they chose that...

I doth my cap to thee Sir.

I never knew farms had such a demand for masks.

How does the cost price per unit stack up vs sales revenue forecasts on orders to date?

https://www.londonstockexchange.com/news-article/DDDD/investor-conference-participation/14885244

Been reading up what happened to Seres Therapeutics, when it’s stock value increased ten-fold from circa $4 per share to almost $40 per share on the below announcement in August last year, linked to a successful Phase III trial to treat CDI - https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-announces-positive-topline-results-ser-109

Given that 4D’s focus is on much more serious diseases, most notably cancer, and we have already seen excellent results to date, should MRx0518 be successful either in combination with Keytruda or as a monotherapy, I would anticipate an increase in SP of perhaps 25 x current levels as an absolute minimum.

https://www.evaluate.com/vantage/articles/interviews/spac-makes-it-happen-4d-pharma

So we had a red day, as did the majority of the market today.

To anyone concerned about what is perceived to be a dilution, look at the bigger picture to understand who the funders are and what that funding will enable 4D to do: accelerate trials and product development, so we can grow into an absolute beast of a biotech co even sooner.

I wasn’t overly surprised nor concerned about this news or today’s dip, I see it as a defined path to accelerated growth and massive profits. Duncan Peyton is no fool and if you look at his track record, he he has history of delivering shareholder value.

I’m not a huge holder, I have 10,000 shares split 70/30 4D/LOAC and this feels like one of the best stocks I have ever held.

Have a great weekend people. Our rewards are ahead.

“If 40% of the company is in the hands of sector specialist II’s, that’s fine with me.”

My post was ambiguous. If up to 40% of additional shares are issued to II’s, I am very comfortable with this.

There will be those who always see the negatives and then those who can see the bigger picture. Given the general market lethargy at present, I suspect there will be opportunities to add further pre-merger.

Thanks Trek, nice to see some positive input.

If 40% of the company is in the hands of sector specialist II’s, that’s fine with me.

Any fundraising should come as zero surprise, it’s been in many previous RNS announcements that the merger would provide working capital to Q3.

Personally, I will be taking advantage of any dips to top up.

22nd March guys and gals!

https://twitter.com/4dpharmaplc/status/1365197309076774915?s=20

Hold onto your hats, it’s going to be an epic ride!

https://www.londonstockexchange.com/news-article/DDDD/posting-of-circular/14879747

General Meeting called by 4D to approve merger.

It’s really happening!